Long-term health registry for people with CIDP
Part of Brain & nervous system, Immune system & allergy clinical trials.
This registry study collects long-term health information from people with CIDP across the US, UK, and Germany. By participating, you help researchers better understand the disease and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a neurologist-confirmed diagnosis of CIDP.
- You live in the United States, the United Kingdom, or Germany.
- You have access to a smartphone, tablet, computer, or laptop.
- You are willing to provide consent in your local language.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a blood-filtering treatment called immunoadsorption can help people with CIDP. It is for adults who are already receiving or starting IVIg or MP therapy.
This study looks at how well efgartigimod works in everyday use for people with chronic inflammatory demyelinating polyneuropathy (CIDP). It aims to understand the real-world benefits of this treatment.
This trial studies people with a slowly worsening nerve problem (chronic dysimmune polyneuropathy) that is likely caused by the immune system. The goal is to learn about the patterns of this condition using clinical exams and nerve function tests (electrophysiology).
This study uses ultrasound to look at nerves in people with CIDP to help guide treatment. It aims to see if ultrasound can help doctors choose the best therapy for each person.
This study looks at how well current treatments work for people with CIDP (a nerve condition causing weakness). It tracks symptoms and daily function over time to help doctors understand which treatments may work best.
This study is a registry that collects information from people diagnosed with certain neuroinflammation conditions. It may help doctors learn how these diseases behave over time and support future research.
Hear when a new Chronic Inflammatory Demyelinating Polyneuropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.